Ask AI

A New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion

Understand the latest evidence for novel and emerging IgA nephropathy (IgAN) therapies, including their mechanistic targets and how these modulate the complement pathway. Then take home strategies to incorporate these therapies in patient-centered care plans that prioritize the slowing of IgAN progression and optimize long-term outcomes, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Activities

New IgAN Paradigm
A New Paradigm In IgAN Management: How Diagnostics and Treatment Are Evolving
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with the American Kidney Fund (AKF)

Supporters

Supported by independent educational grants from Novartis Pharmaceuticals Corporation and Vertex Pharmaceuticals Incorporated.

Novartis Pharmaceuticals Corporation

Vertex Pharmaceuticals Incorporated

Partners

American Kidney Fund

ProCE Banner